Alzamend Neuro Inc.

1.17
-0.01 (-0.85%)
Jan 23, 2025, 3:07 PM - Market open

Alzamend Neuro Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for ALZN stock have an median target of 32, with a low estimate of 32 and a high estimate of 32. The median target predicts an increase of 2635.04% from the current stock price of 1.17.

Analyst Consensus: Buy
Target Low Average Median High
Price $32 $32 $32 $32
Change 2635.04% 2635.04% 2635.04% 2635.04%

AI Analyst Report

Ascendiant Capital has reaffirmed a Buy rating for... Unlock content with Pro Subscription

Updated Dec 16, 2024

Rating Nov 24Dec 24
Strong Buy 00
Buy 11
Hold 00
Sell 00
Strong Sell 00
Total 1 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-1.68
from -14.72
Increased by 88.6%
EPS Next Year
-1.71
from -1.68
Increased by -1.8%
Fiscal Year FY24FY25FY26FY27FY28
Revenue n/a n/a n/a 31.55M 132.71M
Revenue Growth n/a n/a n/a n/a 320.62%*
EPS -14.72 -1.68 -1.71 -2 13.90
EPS Growth n/a 88.59%* -1.79%* -16.96%* 795%*
Net Income -9.95M -1.14M -1.16M -1.35M 9.40M
Net Income Growth n/a 88.57%* -1.79%* -16.96%* 795%*
EBITDA -9.89M n/a n/a n/a n/a
EBITDA Growth n/a n/a n/a n/a n/a
No. Analysts - n/a n/a 1 1
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
* This value depends on the forecast

We use cookies to ensure that we give you the best experience on our website. Read Privacy Policy.